A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants
Clinical trial NCT05515601 · COMPLETED
Trial details
- NCT number
- NCT05515601
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2023-02-20
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.